Pharma channel feed – Endpoints News

Pharma channel feed

Roche's triplet involving Tecentriq clears the PFS bar for melanoma when added to BRAF/MEK combo

6 years ago

House passes Pelosi drug pricing bill on party-line vote

6 years ago

AstraZeneca joins Merck, Bristol-Myers in China's checkpoint race as regulators OK first PD-L1

6 years ago

Amgen puts its foot down in shiny new South San Francisco hub as it reorganizes R&D ops

6 years ago

Republicans unveil a drug price bill to rival the Democrats — promising lower prices and more cures

6 years ago

US biosimilar launches about to turn a corner

6 years ago

While Novartis combats generic onslaught in the courts, FDA approves first Gilenya copycats

6 years ago

In a win for industry, Trump administration issues scathing review of Pelosi drug pricing bill

6 years ago

Roche moves deeper into Merck territory with Tecentriq/chemo OK in frontline NSCLC

6 years ago

Shaking up China's PD-(L)1 reimbursement landscape, Innovent, Eli Lilly earn coveted spot on national coverage

6 years ago

J&J, Teva and four others under criminal probe as feds investigate opioid makers for failing to monitor distribution

6 years ago

FDA approves 5 new costly drugs well ahead of PDUFA dates

6 years ago

Feds add fraud charges to the multitude of accusations made against former MiMedx execs

6 years ago

Aquestive nabs FDA OK for oral film version of generic ALS drug

6 years ago

FDA releases 81 product-specific guidances

6 years ago

Sanofi's strategy head to retire by month end, as company gears up for December strategic update

6 years ago

Ahead of strategic update, new Sanofi CEO mulls options for consumer healthcare arm — reports

6 years ago

Eli Lilly touts $400M manufacturing expansion, 100 new jobs to much fanfare in Indianapolis — even though it's been chopping staff

6 years ago

AstraZeneca loses another executive to biotech, as Badrul Chowdhury moves to Savara

6 years ago

Elizabeth Warren proposes using compulsory licensing, antitrust actions to break biopharma’s control of drug pricing — and here are the blockbusters she’s targeting first

6 years ago

After a late-stage miss, Novartis touts another Entresto analysis to convince the FDA to expand the blockbuster's label

6 years ago

FTC clears Bristol-Myers’ $74B deal to buy Celgene — but Dems signal a potential hard shift against Big Pharma M&A

6 years ago

FDA panel largely opposes expanding use of Lilly, Boehringer's SGLT2 inhibitor to type 1 diabetics

6 years ago

Merck shutters French research site in a reorganization aimed at eliminating more than 200 jobs

6 years ago

First page Previous page 262 263 264265266 267 268 Next page Last page